Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L&L Bioresearch is a contract research organization (CRO) that provides comprehensive bioanalytical and drug metabolism and pharmacokinetics (DMPK) services to the pharmaceutical and biotechnology industries. The company specializes in high-quality analytical support for both small molecules and biologics across various stages of drug discovery and development. Their service offerings include method development and validation, sample analysis, and pharmacokinetic/pharmacodynamic (PK/PD) modeling. L&L Bioresearch operates facilities that adhere to Good Laboratory Practice (GLP) standards, ensuring regulatory compliance for their global client base. By leveraging advanced mass spectrometry and ligand binding assay technologies, the company helps accelerate the transition of drug candidates from preclinical research to clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L&L.